Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Total Current Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Current Liabilities ₹455 Cr₹327 Cr₹269 Cr₹209 Cr

What is the latest Total Current Liabilities ratio of CORONA REMEDIES ?

The latest Total Current Liabilities ratio of CORONA REMEDIES is ₹455 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹455 Cr
Mar2025₹327 Cr
Mar2024₹269 Cr
Mar2023₹209 Cr

How is Total Current Liabilities of CORONA REMEDIES Trending?

Years Total Current Liabilities % Change
Mar2026 ₹455 Cr
38.96
Mar2025 ₹327 Cr
21.68
Mar2024 ₹269 Cr
28.46
Mar2023 ₹209 Cr -

Compare Total Current Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,072.3 Cr 4.4% 4.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,271.0 Cr -0.5% -0.3% 18.9% Stock Analytics
DIVIS LABORATORIES ₹226,843.0 Cr 3.1% 18.9% 33.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,000.0 Cr -1.5% -1.6% 35.6% Stock Analytics
CIPLA ₹118,072.0 Cr -0.9% 1.6% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,073.0 Cr 2% -3.8% -0.7% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

4.4%

4.4%

NA
SENSEX

-0.8%

0.5%

-3.8%


You may also like the below Video Courses